Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?-Reference-Cited by-同舟云学术

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?

Published:2022-12-07 Issue:1 Volume:37 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clinical Transplantation

Author:

Coupier Antoine¹,Gallien Yves²,Boillot Olivier¹³,Walter Thomas³⁴,Guillaud Olivier¹,Vallin Mélanie¹,Thimonier Elsa¹,Erard Domitille⁵,Dumortier Jérôme¹³^ORCID

Affiliation:

1. Fédération des Spécialités Digestives Hôpital Edouard Herriot Hospices Civils de Lyon Lyon France

2. Université de Paris Paris France

3. Université Claude Bernard Lyon 1 Lyon France

4. Service d'Oncologie Digestive Hôpital Edouard Herriot Hospices Civils de Lyon Lyon France

5. Service d'Hépato‐gastroentérologie Hôpital de la Croix‐Rousse Hospices Civils de Lyon Lyon France

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14841

Reference32 articles.

1. Survie globale du receveur après greffe hépatique (1993‐2014). (consulted the March 20 2022) Available from:https://www.agence‐biomedecine.fr/annexes/bilan2015/donnees/organes/2005‐foie/synthese.htm

2. Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study

3. De Novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival

4. Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences

5. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients